Non-esterified fatty acids and the liver: Why is insulin secreted into the portal vein?

Diabetologia

Volumn 43, Issue 7, 2000, Pages 946-952

  Bergman, R N ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Adipocyte; Central adiposity; Gluconeogenesis; Liver; Single gateway hypothesis

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN;

ADIPOCYTE; FATTY ACID BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE UTILIZATION; HORMONE ACTION; HUMAN; INSULIN BINDING; INSULIN CLEARANCE; INSULIN RELEASE; INSULIN RESISTANCE; LIVER CELL; LIVER FUNCTION; NONHUMAN; OBESITY; PORTAL VEIN; PRIORITY JOURNAL; REVIEW;

EID: 0033911870     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051474     Document Type: Review

References (54)

1. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR (1992) Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340: 925-929
2. Mykkanen L, Haffner SM, Ronnemaa T, Bergman R, Laakso M (1997) Low insulin sensitivity is associated with clustering of cardiovascular risk factors. Am J Epidemiol 146: 315-321
3. Modan M, Halkin H, Almog S et al. (1985) Hyperinsulinemia: a link between hypertension, obesity, and glucose intolerance. J Clin Invest 75: 809-817
4. Giovannucci E (1995) Insulin and colon cancer. Cancer Causes Control 6: 164-179
5. Reaven GM (1988) Role of insulin resistance in human disease (Banting Lecture). Diabetes 37: 1595-1607
6. Saltiel AR, Olefsky JM (1996) Thiazolidinediones in the treatment of insulin resistance and Type II diabetes. Diabetes 45: 1661-1669
7. Berkowitz K, Peters R, Kjos SL et al. (1996) Effect of troglitazone on insulin sensitivity and pancreatic β-cell function in women at high risk for NIDDM. Diabetes 45: 1572-1579
8. Martin G, Schoonjans K, Staels B, Auwerx J (1998) PPAR-γ activators improve glucose homeostasis by stimulating fatty acid uptake in the adipocytes. Atherosclerosis 137: S75-S80
9. McGarry JD, Dobbins RL (1999) Fatty acids, lipotoxicity and insulin secretion. Diabetologia 42: 128-138
10. Dresner A, Laurent D, Marcucci M et al. (1999) Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 103: 253-259
11. Roden M, Price TB, Perseghin G et al. (1996) Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97: 2859-2865
12. Ganong WF (1987) Review of Medical Physiology, 13th edn. Appleton and Lange, East Norwalk
13. Rizza RA, Mandarino LJ, Gerich JE (1981) Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol 240: E630-E639
14. Hems DA, Whitton PD (1980) Control of hepatic glycogenolysis. Physiol Rev 60: 1-50
15. Hers HG, Hue L (1983) Gluconeogenesis and related aspects of glycolysis. Annu Rev Biochem 52: 617-653
16. Levine R, Fritz IB (1956) The relation of insulin to liver metabolism. Diabetes 5: 209-219
17. Bradley DC, Poulin RA, Bergman RN (1992) Dynamics of hepatic and peripheral insulin effects suggest common rate-limiting step in vivo. Diabetes 42: 296-306
18. Pigon J, Giacca A, Ostenson CG, Lam L, Vranic M, Efendic S (1996) Normal hepatic insulin sensitivity in lean, mild noninsulin-dependent diabetic patients. J Clin Endocrinol Metab 81: 3702-3708
19. Rebrin K, Steil GM, Getty L, Bergman RN (1995) Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 44: 1038-1045
20. Prager R, Wallace P, Olefsky JM (1986) In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects. J Clin Invest 78: 472-481
21. Finegood DT, Bergman RN, Vranic M (1987) Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps: comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 36: 914-924
22. 3H]-glucose: differences in the apparent pattern of insulin resistance depending on the isotope used. J Clin Invest 78: 1479-1486
23. Molina JM, Baron AD, Edelman SV, Brechtel G, Wallace P, Olefsky JM (1990) Use of a variable tracer infusion method to determine glucose turnover in humans. Am J Physiol 258: E16-E23
24. Finegood DT, Bergman RN, Vranic M (1988) Modelling error and apparent isotope discrimination confound estimation of endogenous glucose production during euglycemic glucose clamps. Diabetes 37: 1025-1034
25. 14C]glucose during hyperinsulinemia in humans. Diabetes 38: 97-107
26. Turk D, Alzaid A, Dinneen S, Nair KS, Rizza R (1995) The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues. J Clin Invest 95: 755-762
27. Jensen I, Kruse V, Larsen UD (1991) Scintigraphic studies in rats: kinetics of insulin analogues covering wide range of receptor affinities. Diabetes 40: 628-632
28. Bergman RN (1997) New concepts in extracellular signaling for insulin action: the single gateway hypothesis. Recent Prog Horm Res 42: 359-385
29. Ader M, Bergman RN (1990) Peripheral effects of insulin dominate suppression of fasting hepatic glucose production. Am J Physiol 258: E1020-E1032
30. Rebrin K, Steil GM, Mittelman S, Bergman RN (1996) Causal linkage between insulin regulation of lipolysis and liver glucose output. J Clin Invest 98: 741-749
31. Mittelman SD, Fu YH, Rebrin K, Steil G, Bergman RN (1997) Indirect effect of insulin to suppress endogenous glucose production is dominant, even with hyperglucagonemia. J Clin Invest 100: 3121-3130
32. Giacca A, Fisher S, Shi ZQ, Gupta R, Lickley HL, Vranic M (1992) Importance of peripheral insulin levels for insulin-induced suppression of glucose production in depancreatized dogs. J Clin Invest 90: 1769-1777
33. Lewis GF, Zinman B, Groenewoud Y, Vranic M, Steiner G, Giacca A (1996) Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans. Diabetes 45: 454-462
34. Lewis GF, Vranic M, Harley P, Giacca A (1997) Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans. Diabetes 46: 1111-1119
35. Lewis GF, Vranic M, Giacca A (1997) Glucagon enhances the direct suppressive effect of insulin on hepatic glucose production in humans. Am J Physiol 272: E371-E378
36. Lewis GF, Carpentier A, Vranic M, Giacca A (1999) Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with Type 2 diabetes. Diabetes 48: 570-576
37. Exton JH, Corbin JG, Park CR (1969) Control of gluconeogenesis in liver: IV. Differential effects of fatty acids and glucagon on ketogenesis and gluconeogenesis in the perfused rat liver. J Biol Chem 244: 4095-4102
38. O'Meara NM, Blackman JD, Sturis J, Polonsky KS (1993) Alterations in the kinetics of C-peptide and insulin secretion in hyperthyroidism. J Clin Endocrinol Metab 76: 79-84
39. Glinsmann WH, Hern EP, Lynch A (1969) Intrinsic regulation of glucose output by rat liver. Am J Physiol 216: 698-703
40. 14C]glucose. Diabetes 35: 642-648
41. Best JD, Kahn SE, Ader M, Watanabe RM, Ni T-C, Bergman RN (1996) Role of glucose effectiveness in the determination of glucose tolerance. Diabetes Care 19: 1018-1030
42. Mittelman SD, Bergman RN (2000) Inhibition of lipolysis causes suppression of endogenous glucose production independent of changes in insulin. Am J Physiol (in press)
43. Chen X, Iqbal N, Boden G (1999) The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. J Clin Invest 103: 365-372
44. Clore JN, Glickman PS, Helm ST, Nestler JE, Blackard WG (1991) Evidence for dual control mechanism regulating hepatic glucose output in nondiabetic men. Diabetes 40: 1033-1040
45. Puhakainen I, Koivisto VA, Yki-Jarvinen H (1991) No reduction in total hepatic glucose output by inhibition of gluconeogenesis with ethanol in NIDDM patients. Diabetes 40: 1319-1327
46. Massillon D, Chen W, Barzilai N et al. (1998) Carbon flux via the pentose phosphate pathway regulates the hepatic expression of the glucose-6-phosphatase and phosphoenolpyruvate carboxykinase genes in conscious rats. J Biol Chem 273: 228-234
47. Dea MK, Kim SP, Kabir M, Youn JH, Bergman RN (2000) Insulin suppresses glucose production by inhibiting glucose-6-phosphatase. Diabetes 49 [Suppl 1]: A282
48. Mittelman SD, van Citters GW, Kim SP, Davis DA, Dea MK, Bergman RN (2000) The longitudinal compensation for fat induced insulin resistance includes reduced insulin clearance and enhanced B-cell response. Diabetes (in press)
49. Bergman RN, Phillips LS, Cobelli C (1981) Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and B-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68: 1456-1467
50. Bergman RN (1989) Toward physiological understanding of glucose tolerance: minimal-model approach (Lilly Lecture). Diabetes 38: 1512-1527
51. Svedberg J, Stromblad G, Wirth A, Smith U, Bjorntorp P (1991) Fatty acids in the portal vein of the rat regulate hepatic insulin clearance. J Clin Invest 88: 2054-2058
52. Wiesenthal SR, Sandhu H, McCall RH et al. (1999) Free fatty acids impair hepatic insulin extraction in vivo. Diabetes 48: 766-774
53. Arner P, Pollare T, Lithell H (1991) Different aetiologies of Type 2 (non-insulin-dependent) diabetes mellitus in obese and non-obese subjects. Diabetologia 34: 483-487
54. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider U (1998) The metabolically obese, normal-weight individual revisited. Diabetes 47: 699-713